» Articles » PMID: 36237134

Influence of Vitamin D on Sarcopenia Pathophysiology: A Longitudinal Study in Humans and Basic Research in Knockout Mice

Abstract

Background: Vitamin D is an essential nutrient in musculoskeletal function; however, its relationship to sarcopenia remains ambiguous, and the mechanisms and targets of vitamin D activity have not been elucidated. This study aimed to clarify the role of vitamin D in mature skeletal muscle and its relationship with sarcopenia.

Methods: This epidemiological study included 1653 community residents who participated in both the fifth and seventh waves of the National Institute for Longevity Sciences, Longitudinal Study of Aging and had complete background data. Participants were classified into two groups: vitamin D-deficient (serum 25-hydroxyvitamin D < 20 ng/mL) and non-deficient (serum 25-hydroxyvitamin D ≥ 20 ng/mL); they underwent propensity-score matching for background factors (age, sex, height, weight, comorbidities, smoker, alcohol intake, energy intake, vitamin D intake, steps, activity, season and sarcopenia). Changes in muscle strength and mass over the 4-year period were compared. For basic analysis, we generated Myf6 Vitamin D Receptor (VDR)-floxed (Vdr ) mice with mature muscle fibre-specific vitamin D receptor knockout, injected tamoxifen into 8-week-old mice and analysed various phenotypes at 16 weeks of age.

Results: Grip strength reduction was significantly greater in the deficient group (-1.55 ± 2.47 kg) than in the non-deficient group (-1.13 ± 2.47 kg; P = 0.019). Appendicular skeletal muscle mass reduction did not differ significantly between deficient (-0.05 ± 0.79 kg) and non-deficient (-0.01 ± 0.74 kg) groups (P = 0.423). The incidence of new cases of sarcopenia was significantly higher in the deficient group (15 vs. 5 cases; P = 0.039). Skeletal muscle phenotyping of Vdr mice showed no significant differences in muscle weight, myofibre percentage or myofibre cross-sectional area; however, both forelimb and four-limb muscle strength were significantly lower in Vdr mice (males: forelimb, P = 0.048; four-limb, P = 0.029; females: forelimb, P < 0.001; four-limb, P < 0.001). Expression profiling revealed a significant decrease in expression of sarcoendoplasmic reticulum Ca -ATPase (SERCA) 1 (P = 0.019) and SERCA2a (P = 0.049) genes in the Vdr mice. In contrast, expression of non-muscle SERCA2b and myoregulin genes showed no changes.

Conclusions: Vitamin D deficiency affects muscle strength and may contribute to the onset of sarcopenia. Vitamin D-VDR signalling has minimal influence on the regulation of muscle mass in mature myofibres but has a significant influence on muscle strength.

Citing Articles

PDZRN3 regulates adipogenesis of mesenchymal progenitors in muscle.

Iida H, Kawai-Takaishi M, Miyagawa Y, Takegami Y, Uezumi A, Honda T Regen Ther. 2025; 28:473-480.

PMID: 39980718 PMC: 11840944. DOI: 10.1016/j.reth.2025.01.018.


Serum concentrations of different or multiple vitamins and Sarcopenia risk among US adults: insights from NHANES.

Liu L, Ding X, Zhang Y, Li T, Xu P, Ma Y BMC Public Health. 2024; 24(1):3372.

PMID: 39633310 PMC: 11616181. DOI: 10.1186/s12889-024-20897-9.


Vitamin D and Sarcopenia in the Senior People: A Review of Mechanisms and Comprehensive Prevention and Treatment Strategies.

Zhang F, Li W Ther Clin Risk Manag. 2024; 20:577-595.

PMID: 39253031 PMC: 11382659. DOI: 10.2147/TCRM.S471191.


Development and Validation of the Meiji Nutritional Profiling System (Meiji NPS) to Address Dietary Needs of Adults and Older Adults in Japan.

Wakayama R, Drewnowski A, Horimoto T, Saito Y, Yu T, Suzuki T Nutrients. 2024; 16(7).

PMID: 38612970 PMC: 11013258. DOI: 10.3390/nu16070936.


Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies.

Zheng Y, Feng J, Yu Y, Ling M, Wang X Arch Pharm Res. 2024; 47(4):301-324.

PMID: 38592582 DOI: 10.1007/s12272-024-01493-2.


References
1.
Bischoff-Ferrari H, Borchers M, Gudat F, Durmuller U, Stahelin H, Dick W . Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004; 19(2):265-9. DOI: 10.1359/jbmr.2004.19.2.265. View

2.
Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T . Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology. 2003; 144(12):5138-44. DOI: 10.1210/en.2003-0502. View

3.
von Haehling S, Coats A, Anker S . Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021. J Cachexia Sarcopenia Muscle. 2021; 12(6):2259-2261. PMC: 8718061. DOI: 10.1002/jcsm.12899. View

4.
Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T . Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2018; 48(1):16-31. PMC: 6322506. DOI: 10.1093/ageing/afy169. View

5.
Brack A, Conboy M, Roy S, Lee M, Kuo C, Keller C . Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science. 2007; 317(5839):807-10. DOI: 10.1126/science.1144090. View